Immunology: immune response restored by gene therapy in mice
Nature 1985 July 4; 316(6023): 14-15
Showing items related by title, author, creator and subject.
Gene Therapy of Malignant Gliomas: A Phase I Study of IL-4-HSV- TK Gene-Modified Autologous Tumor to Elicit an Immune Response Okada, Hideho; Pollack, Ian F.; Lotze, Michael T.; Lunsford, L. Dade; Kondziolka, Douglas; Lieberman, Frank; Schiff, David; Attanucci, Jason; Edington, Howard; Chambers, William; Robbins, Paul; Baar, Joe; Kinzler, Donna; Whiteside, Theresa; Elder, Elaine (2000-03-01)
Gene therapy of malignant gliomas: a pilot study of vaccination with irradiated autologous glioma and dendritic cells admixed with IL-4 transduced fibroblasts to elicit an immune response Okada, Hideho; Pollack, Ian F.; Lieberman, Frank; Lunsford, L. Dade; Kondziolka, Douglas; Schiff, David; Attanucci, Jason; Edington, Howard; Chambers, William; Kalinski, Pawel; Kinzler, Donna; Whiteside, Theresa; Elder, Elaine; Potter, Douglas (2001-03-20)
French gene therapy group reports on the adverse event in a clinical trial of gene therapy for X-linked severe combined immune deficiency (X-SCID). Position statement from the European Society of Gene Therapy European Society of Gene Therapy [ESGT] (2003-01)